Journal Article

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Siegal, Gene P., Wei, Shi, Dal Zotto, Valeria L., Huang, Xiao, Harada, Shuko, Bartow, Brooke B., Anderson, Sarah A.

2024

Overview

Purpose The importance of a TP53 mutation has been demonstrated in several tumor types, including breast cancer (BC). However, the accuracy of p53 protein expression as a predictor of gene mutation has not been well studied in BC. Therefore, we evaluated p53 protein expression associated with TP53 mutations in breast cancers from 64 patients. Methods TP53 mutation was examined using next-generation sequencing (NGS). p53 protein expression was examined using immunohistochemistry (IHC). Results Among the 64 BCs, 55% demonstrated abnormal expression patterns including 27% overexpression, 22% null, 6% equivocal with 45% having a wild-type pattern. A TP53 mutation was present in 53% (34/64) of tumors including 30% (19/64) demonstrating a missense mutation, 11% (7/64) with a frameshift mutation, 11% (7/64) with a nonsense mutation, and 3% (1/64) with a splice site mutation. Abnormal expression of p53 protein was present in 33 of 34 (97%) tumors carrying a TP53 mutation; conversely, a wild-type pattern was present in 28 of 30 (93%) tumors without a detectable mutation ( p  < 0.0001). The majority of BCs with a p53 IHC overexpression pattern (15/17, 88%) contained a missense TP53 mutation; while the majority of BCs with a null pattern (12/14, 86%) contained a truncating mutation ( p  < 0.0001). The BCs with a null pattern are associated with a high Nottingham histological grade and a triple-negative phenotype when compared to those demonstrating overexpression ( p  < 0.05). Conclusion These findings suggest that p53 IHC can be a potential surrogate for TP53 mutations in BC. Different p53 expression patterns may correlate with specific TP53 genetic mutations in BC.

• Publisher: Springer US,Springer,Springer Nature B.V
• Subject: Adult / Aged / Aged, 80 and over / Biomarkers, Tumor - genetics / Biomarkers, Tumor - metabolism / Breast cancer / Breast carcinoma / Breast Neoplasms - genetics / Breast Neoplasms - metabolism / Breast Neoplasms - pathology / Female / Frameshift mutation / Gene mutations / Genetic aspects / High-Throughput Nucleotide Sequencing / Humans / Immunohistochemistry / Medicine / Medicine & Public Health / Middle Aged / Missense mutation / Mutation / Next-generation sequencing / Nonsense mutation / Oncology / p53 Protein / Phenotypes / Point mutation / Protein expression / Proteins / Tumor proteins / Tumor Suppressor Protein p53 - genetics / Tumor Suppressor Protein p53 - metabolism / Tumors